Published in Law and Health Weekly, March 29th, 2008
Peter Phildius, Avitar's Chairman and CEO said, "The construction industry represents a significant business opportunity for Avitar, a revenue potential of $1M over the next year. Industry leaders are now moving to incorporate Avitar's on-site oral fluid technology for random drug testing, as well as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.